Novo Nordisk Foundation
Tandem Programme – Translational research collaboration between Basic and Clinical Researchers
Call opens 18 November 2026; closes 21 January 2027 at 2:00pm Copenhagen time
Last updated:
The Tandem Programme funds translational research collaborations in Denmark between one basic and one clinical researcher, with up to DKK 13 million per project over four years. The call targets bioscience, basic biomedicine, and clinical/translational medicine projects where the main applicant holds ≥75% primary employment in Denmark, while the co-applicant may be based abroad. This is an annual programme emphasizing the bridge between bench and bedside research.
Details
| Funder | Novo Nordisk Foundation |
| Budget | Up to DKK 13M per grant |
| Deadline | 21 January 2027 |
| Duration | 4 years |
| Consortium | Required — one basic researcher and one clinical researcher applying together as a tandem pair |
| Frequency | Annual |
| Next round | 2027-11 |
| Eligible countries | DK |
Eligibility & scope
Supports translational research collaborations between basic and clinical researchers based in Denmark. Open to research leaders at mid-career (Associate Prof.) and established (Prof.) levels. Covers bioscience, basic biomedicine, and clinical/translational medicine. Results announced beginning of June 2027.
Who Should Apply
- •Main applicant with ≥75% primary employment at a Danish university, hospital, or non-profit research institution
- •Basic and clinical researcher pairs (co-applicant may be abroad)
- •Projects bridging bench science and clinical application in bioscience, biomedicine, or translational medicine
- •Established researchers with a track record of collaborative translational work
Key Dates
- •Next deadline expected October 2026 (verify exact date on Novo Nordisk Foundation website)
- •Four-year project duration
- •Annual call frequency
Tips for Applicants
- ✓The consortium is mandatory and gating: a single-investigator proposal will not be reviewed. Ensure your co-applicant has a named role and commitment letter before submission.
- ✓Reviewers prioritise concrete translational pathways, not just co-location of basic and clinical labs. Make the mechanistic link and clinical relevance explicit in your proposal narrative.
- ✓The main applicant's Danish employment threshold is strictly enforced at ≥75%; document this clearly in your institutional letter.
Frequently Asked Questions
How much funding does the Tandem Programme provide?
Up to DKK 13 million per project over four years.
Who is eligible to be the main applicant for the Tandem Programme?
A researcher with ≥75% primary employment at a Danish university, hospital, or non-profit research institution.
Can my co-applicant be based outside Denmark?
Yes, the co-applicant (clinical or basic researcher) may be based abroad, but the main applicant must be Denmark-based.
When is the next Tandem Programme deadline?
The next call is expected in October 2026; verify the exact date on the Novo Nordisk Foundation website.
Summary generated by AI based on published grant information. Always verify details on the funder's website.
Similar grants
Tandem Programme
Novo Nordisk FoundationDeadline: 21 Jan 2027Up to DKK 13 mio. per grantClinical Emerging Investigator
Novo Nordisk FoundationDeadline: 20 Jan 2027Up to DKK 12,500,000 per grantBorregaard Clinical Ascending Investigator
Novo Nordisk FoundationDeadline: 20 Jan 2027Up to DKK 11 mio. per grantClinical Distinguished Investigator
Novo Nordisk FoundationDeadline: 20 Jan 2027Up to DKK 11 mio.Projektstøtte i Klinisk og Translationel Lægevidenskab
Novo Nordisk FoundationUp to DKK 4,500,000 per project (max DKK 1,500,000/year); DKK 76M total pool; DKK 13.5M earmarked for IDs & CMDs theme
Browse Related
Could Tandem Programme – Translational research collaboration between Basic and Clinical Researchers be right for you?
See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.
See my matches free →